'The Next Chunk of Gold:' New CRISPR Fight Brewing
STAT's special report on 'legacies and lucrative drug profits'
Revolutionary gene therapies are the flavor of the day in many circles, including at California’s $12 billion stem cell and gene therapy program. The road seemed clear to create one-and-done cures for previously uncurable, horrible afflictions.
But obstacles have arisen involving the “revolution.” The respected STAT online b…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.